Cordant, Inc. Elanco Animal Health Inc Call Options Transaction History
Cordant, Inc.
- $190 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ELAN
# of Institutions
449Shares Held
480MCall Options Held
4.47MPut Options Held
730K-
Dodge & Cox San Francisco, CA83.3MShares$948 Million0.74% of portfolio
-
Primecap Management CO Pasadena, CA51.2MShares$582 Million0.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA48.8MShares$555 Million0.01% of portfolio
-
Black Rock Inc. New York, NY23.3MShares$265 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD21MShares$239 Million0.19% of portfolio
About Elanco Animal Health Inc
- Ticker ELAN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 474,113,984
- Market Cap $5.4B
- Description
- Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...